<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-482</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8610</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Результативность использования передвижных маммографических установок при скрининге рака молочной железы</article-title><trans-title-group xml:lang="en"><trans-title>The effectiveness of a mobile mammography units in breast cancer screening</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1490-0427</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каприн</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaprin</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каприн Дмитрий Андреевич, к.м.н., ассистент кафедры общественного здоровья и здравоохранения</p><p>127006, Москва, ул. Долгоруковская, д. 4</p></bio><bio xml:lang="en"><p>Dmitri A. Kaprin, Cand. Sci. (Med.), Assistant Professor of the Department of Public Health and Healthcare</p><p>4, Dolgorukovskaya St., Moscow, 127006</p></bio><email xlink:type="simple">kaprind@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4134-3371</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перхов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Perkhov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перхов Владимир Иванович, д.м.н., доцент, главный научный сотрудник</p><p>105064, Москва, ул. Воронцово поле, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Vladimir I. Perkhov, Dr. Sci. (Med.), Associate Professor, Chief Researcher</p><p>12, Bldg. 1, Vorontsovo Pole St., 105064, Moscow</p></bio><email xlink:type="simple">finramn@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1704-876X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>M. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денисова Мария Николаевна, д.фарм.н., главный научный сотрудник</p><p>105064, Москва, ул. Воронцово поле, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Maria N. Denisova, Dr. Sci. (Farm.), Chief Researcher</p><p>12, Bldg. 1, Vorontsovo Pole St., 105064, Moscow</p></bio><email xlink:type="simple">denisovamn@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет медицины (РосУниМед)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian University of Medicine (ROSUNIMED)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный научно-исследовательский институт общественного здоровья имени Н.А. Семашко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Semashko National Research Institute of Public Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2024</year></pub-date><volume>0</volume><issue>21</issue><fpage>96</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каприн Д.А., Перхов В.И., Денисова М.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Каприн Д.А., Перхов В.И., Денисова М.Н.</copyright-holder><copyright-holder xml:lang="en">Kaprin D.A., Perkhov V.I., Denisova M.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8610">https://www.med-sovet.pro/jour/article/view/8610</self-uri><abstract><p>Рак молочной железы (РМЖ) остается ведущей причиной смертности женского населения. В целях выявления заболевания на ранних стадиях проводятся скрининговые исследования. При этом отечественные авторы подчеркивают безальтернативность профилактической маммографии при скрининге РМЖ и перспективность использования передвижных маммографов для ранней диагностики РМЖ и предраковых заболеваний молочной железы (МЖ).</p><sec><title>Цель</title><p>Цель. Оценить результаты применения передвижных маммографических установок для активного и раннего выявления РМЖ.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Использованы методы контент-анализа, информационные и аналитические материалы российских и зарубежных исследователей, формы федерального статистического наблюдения. Для анализа полученных данных были использованы статистические методы исследования.</p></sec><sec><title>Результаты</title><p>Результаты. Регрессионный анализ с очень низкой вероятностью ошибки (р = 0,001) показал, что, чем больше в субъектах Российской Федерации общие объемы рентгенологических исследований МЖ с профилактическими целями, тем выше доля случаев активного выявления РМЖ, хотя эта взаимосвязь довольно слабая. С учетом полученного значения R2 (0,192) всего только 19,2% случаев увеличения доли случаев РМЖ, выявленных активно, можно объяснить увеличением объемов профилактических маммографий. Корреляционный анализ показал, что объемы профилактических маммографий, выполненных с использованием передвижных установок в субъектах Российской Федерации, оказались не связаны ни с долей случаев РМЖ, выявленных активно, ни с долей случаев выявления РМЖ на ранних стадиях. При этом стоит отметить, что полученная величина p ≥ 0,5 свидетельствует о статистически незначимом результате оценки связи между переменными, интерпретацию которого следует выполнять с осторожностью.</p></sec><sec><title>Выводы</title><p>Выводы. Несмотря на высокую стоимость передвижных маммографических установок, увеличение их числа в субъектах Российской Федерации и рост объемов их деятельности, вклад этих диагностических устройств в решение проблемы ранней и активной диагностики РМЖ остается неопределенным. Более перспективными являются персонализированные подходы к своевременному выявлению раковых заболеваний, в том числе РМЖ, основанные на оценке индивидуального риска их возникновения.</p></sec></abstract><trans-abstract xml:lang="en"><p>Breast cancer remains the leading cause of death in the female population. Screening studies are conducted in order to detect the disease at an early stage. At the same time, domestic authors emphasize the lack of alternatives to preventive mammography in breast cancer screening and the prospects of using mobile mammographs for early diagnosis of breast cancer and precancerous breast diseases.</p><sec><title>Aim</title><p>Aim. To evaluat the results of the use of mobile mammography units for active and early detection of breast cancer.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The research uses methods of content analysis, information and analytical materials of Russian and foreign researchers, and forms of federal statistical observation. Statistical research methods were used to analyze the data obtained.</p></sec><sec><title>Results</title><p>Results. Regression analysis with a very low probability of error (p = 0.001) showed that the larger the total volume of mammographic studies with preventive purposes in the subjects of the Russian Federation, the higher the proportion of cases of active detection of breast cancer, although this relationship is rather weak. Taking into account the obtained value of R2 (0.192), only 19.2% of the increase in the proportion of breast cancer cases detected actively can be explained by an increase in the volume of preventive mammograms. The correlation analysis showed that the volumes of preventive mammograms performed using mobile devices in the subjects of the Russian Federation were not associated with either the proportion of breast cancer cases detected actively or with the proportion of breast cancer cases detected in the early stages. At the same time, it is worth noting that the obtained value of p ≥ 0.5 indicates a statistically insignificant result of evaluating the relationship between variables, the interpretation of which should be performed with caution.</p></sec><sec><title>Conclusion</title><p>Conclusion. Despite the high cost of mobile mammography units, the increase in their number in the subjects of the Russian Federation and the growth in their activities, the contribution of these diagnostic devices to solving the problem of early and active diagnosis of breast cancer remains uncertain. More promising are personalized approaches to the timely detection of cancers, including breast cancer, based on an assessment of the individual risk of their occurrence.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>маммография</kwd><kwd>мобильные маммографические аппараты</kwd><kwd>стационарные маммографические аппараты</kwd><kwd>рак молочной железы</kwd><kwd>скрининг</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mammography</kwd><kwd>mobile mammography devices</kwd><kwd>stationary mammography devices</kwd><kwd>breast cancer</kwd><kwd>screening</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hu S, Zhao R, Cui Y, Zhang D, Ge Y. Identifying the uneven distribution of health and education services in China using open geospatial data. Geography and Sustainability. 2023;4(2):91–99. https://doi.org/10.1016/j.geosus.2023.01.002.</mixed-citation><mixed-citation xml:lang="en">Hu S, Zhao R, Cui Y, Zhang D, Ge Y. Identifying the uneven distribution of health and education services in China using open geospatial data. Geography and Sustainability. 2023;4(2):91–99. https://doi.org/10.1016/j.geosus.2023.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wang F. Why public health needs GIS: a methodological overview. Ann GIS. 2020;26(1):1–12. https://doi.org/10.1080/19475683.2019.1702099.</mixed-citation><mixed-citation xml:lang="en">Wang F. Why public health needs GIS: a methodological overview. Ann GIS. 2020;26(1):1–12. https://doi.org/10.1080/19475683.2019.1702099.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шартова НВ, Грищенко МЮ, Ватлина ТВ. Территориальная доступность медицинских учреждений для жителей севера России. Вестник Московского университета. Серия 5. География. 2023;(5):104–114. https://doi.org/10.55959/MSU0579-9414.5.78.5.10.</mixed-citation><mixed-citation xml:lang="en">Shartova NV, Grishchenko MYu, Vatlina TV. Territorial accessibility of medical institutions for the residents of the North of Russia. Vestnik Moskovskogo Universiteta. Seria 5, Geografia. 2023;(5):104–114. (In Russ.) https://doi.org/10.55959/MSU0579-9414.5.78.5.10.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q, Jackson S, Derakhshan S, Lee L, Pham E, Jackson A, Cutter SL. Urban-rural differences in COVID-19 exposures and outcomes in the South: A preliminary analysis of South Carolina. PloS ONE. 2021;16(2):e0246548. https://doi.org/10.1371/journal.pone.0246548.</mixed-citation><mixed-citation xml:lang="en">Huang Q, Jackson S, Derakhshan S, Lee L, Pham E, Jackson A, Cutter SL. Urban-rural differences in COVID-19 exposures and outcomes in the South: A preliminary analysis of South Carolina. PloS ONE. 2021;16(2):e0246548. https://doi.org/10.1371/journal.pone.0246548.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Климко ВИ, Соломатников ИА, Ходакова ОВ, Кунгурцев ОВ, Страдымов ФИ, Черномырдина ЕВ. Использование картографических схем территориального планирования в здравоохранении. Врач и информационные технологии. 2023;(3):72–83. https://doi.org/10.25881/18110193_2023_3_72.</mixed-citation><mixed-citation xml:lang="en">Klimko VI, Solomatnikov IA, Khodakova OV, Kungurtcev OV, Stradymov FI, Chernomyrdina EV. Using cartographic scheme of territorial planning in health care. Medical Doctor and Information Technology. 2023;(3):72–83. (In Russ.) https://doi.org/10.25881/18110193_2023_3_72.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Семиглазов ВФ, Семиглазов ВВ, Дашян ГА, Криворотько ПВ, Бараш НЮ, Васильев АГ и др. Скрининг рака молочной железы. Поволжский онкологический вестник. 2011;1(1):84–85. Режим доступа: https://cyberleninka.ru/article/n/skrining-raka-molochnoy-zhelezy-6?ysclid=lyols6s3qr204447523.</mixed-citation><mixed-citation xml:lang="en">Semiglazov VF, Semiglazov VV, Dashyan GA, Krivorotʹko PV, Barash NYu, Vasilʹev AG et al. Скрининг рака молочной железы. Oncology Bulletin of the Volga Region. 2011;1(1):84–85. (In Russ.) Available at: https://cyberleninka.ru/article/n/skrining-raka-molochnoy-zhelezy-6?ysclid=lyols6s3qr204447523.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Рассказова ЕА, Рожкова НИ. Скрининг для ранней диагностики рака молочной железы. Исследования и практика в медицине. 2014;1(1):45–49. Режим доступа: https://cyberleninka.ru/article/n/skrining-dlya-ranney-diagnostiki-raka-molochnoy-zhelezy?ysclid=lyolx0t6jy367867041.</mixed-citation><mixed-citation xml:lang="en">Rasskazova EA, Rozhkova NI. Screening for early detection of breast cancer. Research and Practical Medicine Journal. 2014;1(1):45–49. (In Russ.) Available at: https://cyberleninka.ru/article/n/skrining-dlya-ranney-diagnostiki-raka-molochnoy-zhelezy?ysclid=lyolx0t6jy367867041.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Чиссов ВИ, Солодкий ВА, Пак ДД, Рожкова НИ, Ермощенкова МВ, Киреева МН. Скрининг рака молочной железы: история и перспективы. Онкология. Журнал им. П.А. Герцена. 2013;1(2):46–51. Режим доступа: https://elibrary.ru/pypujb.</mixed-citation><mixed-citation xml:lang="en">Chissov VI, Solodkii VA, Pak DD, Rozhkova NI, Ermoshchenkova MV, Kireeva MN. Breast cancer screening: history and prospects. P.A. Herzen Journal of Oncology. 2013;1(2):46–51. (In Russ.) Available at: https://elibrary.ru/pypujb.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Guillaume E, Rollet Q, Launay L, Beuriot S, Dejardin O, Notari A et al. Evaluation of a mobile mammography unit: concepts and randomized cluster trial protocol of a population health intervention research to reduce breast cancer screening inequalities. Trials. 2022;23(1):562. https://doi.org/10.1186/s13063-022-06480-w.</mixed-citation><mixed-citation xml:lang="en">Guillaume E, Rollet Q, Launay L, Beuriot S, Dejardin O, Notari A et al. Evaluation of a mobile mammography unit: concepts and randomized cluster trial protocol of a population health intervention research to reduce breast cancer screening inequalities. Trials. 2022;23(1):562. https://doi.org/10.1186/s13063-022-06480-w.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Рожкова НИ, Боженко ВК. Современные технологии скрининга рака молочной железы. Вопросы онкологии. 2009;55(4):495–500.</mixed-citation><mixed-citation xml:lang="en">Rozhkova NI, Bozhenko VK. Modern technologies for breast cancer screening. Voprosy Onkologii. 2009;55(4):495–500. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Семиглазов ВФ. Скрининг для раннего выявления рака молочной железы. Медицинский Альманах. 2008;(3):63–65. Режим доступа: https://cyberleninka.ru/article/n/skrining-dlya-rannego-vyyavleniya-raka-molochnoy-zhelezy?ysclid=lyombgw9ht187778430.</mixed-citation><mixed-citation xml:lang="en">Semiglazov VF. Screening for early detection of breast cancer. Medical Almanac. 2008;(3):63–65. (In Russ.) Available at: https://cyberleninka.ru/article/n/skrining-dlya-rannego-vyyavleniya-raka-molochnoy-zhelezy?ysclid=lyombgw9ht187778430.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Manukyan NV, Tamamyan GN, Avetisyan AA, Jilavyan SA, Saghatelyan TS. A review of challenges and prospects of mobile mammography screening in developing countries. New Armen Med J. 2023;17(3):105–118. https://doi.org/10.56936/18290825-2023.17.3-105.</mixed-citation><mixed-citation xml:lang="en">Manukyan NV, Tamamyan GN, Avetisyan AA, Jilavyan SA, Saghatelyan TS. A review of challenges and prospects of mobile mammography screening in developing countries. New Armen Med J. 2023;17(3):105–118. https://doi.org/10.56936/18290825-2023.17.3-105.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">De Mil R, Guillaume E, Launay L, Guittet L, Dejardin O, Bouvier V et al. Cost-effectiveness analysis of a mobile mammography unit for breast cancer screening to reduce geographic and social health inequalities. Value Health. 2019;22(10):1111–1118. https://doi.org/10.1016/j.jval.2019.06.001.</mixed-citation><mixed-citation xml:lang="en">De Mil R, Guillaume E, Launay L, Guittet L, Dejardin O, Bouvier V et al. Cost-effectiveness analysis of a mobile mammography unit for breast cancer screening to reduce geographic and social health inequalities. Value Health. 2019;22(10):1111–1118. https://doi.org/10.1016/j.jval.2019.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Masoom S. Analyzing the benefits and downsides of mobile mammography units in Sweden. KTH Royal Institute of Technology: Stockho lm, Sweden; 2022. 100 p. Available at: http://kth.diva-portal.org/smash/record.jsf?pid=diva2%3A1686917&amp;dswid=97.</mixed-citation><mixed-citation xml:lang="en">Masoom S. Analyzing the benefits and downsides of mobile mammography units in Sweden. KTH Royal Institute of Technology: Stockho lm, Sweden; 2022. 100 p. Available at: http://kth.diva-portal.org/smash/record.jsf?pid=diva2%3A1686917&amp;dswid=97.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Killock D. AI outperforms radiologists in mammographic screening. Nat Rev Clin Oncol. 2020;17(3):134. https://doi.org/10.1038/s41571-020-0329-7.</mixed-citation><mixed-citation xml:lang="en">Killock D. AI outperforms radiologists in mammographic screening. Nat Rev Clin Oncol. 2020;17(3):134. https://doi.org/10.1038/s41571-020-0329-7.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lauritzen AD, Rodríguez-Ruiz A, Von Euler-Chelpin MC, Lynge E, Vejborg I, Nielsen M et al. An Artificial intelligence-based mammography screening protocol for breast cancer: outcome and radiologist workload. Radiology. 2022;304(1):41–49. https://doi.org/10.1148/radiol.210948.</mixed-citation><mixed-citation xml:lang="en">Lauritzen AD, Rodríguez-Ruiz A, Von Euler-Chelpin MC, Lynge E, Vejborg I, Nielsen M et al. An Artificial intelligence-based mammography screening protocol for breast cancer: outcome and radiologist workload. Radiology. 2022;304(1):41–49. https://doi.org/10.1148/radiol.210948.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y et al. Risk Factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387–1397. https://doi.org/10.7150/ijbs.21635.</mixed-citation><mixed-citation xml:lang="en">Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y et al. Risk Factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387–1397. https://doi.org/10.7150/ijbs.21635.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905. https://doi.org/10.1097/MD.0000000000036905.</mixed-citation><mixed-citation xml:lang="en">Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905. https://doi.org/10.1097/MD.0000000000036905.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Милованов ВВ, Иванников АА, Колобовникова ОП, Холкина ВМ. Маммографический скрининг: первые результаты, перспективы. Вестник российских университетов. Математика. 2013;18(5–3):2874–2876. Режим доступа: https://cyberleninka.ru/article/n/mammograficheskiy-skrining-pervye-rezultaty-perspektivy?ysclid=lyph8drs8r717072547.</mixed-citation><mixed-citation xml:lang="en">Milovanov VV, Ivannikov AA, Kolobovnikova OP, Kholkina VM. Mammography screening: first results, perspectives. Vestnik rossiyskikh universitetov. Matematika. 2013;18(5–3):2874–2876. (In Russ.) Available at: https://cyberleninka.ru/article/n/mammograficheskiy-skrining-pervye-rezultaty-perspektivy?ysclid=lyph8drs8r717072547.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Комарова ЛЕ. Скрининговая маммография рака молочной железы. За и против? Сибирский онкологический журнал. 2008;S2:9–14. Режим доступа: https://cyberleninka.ru/article/n/skriningovaya-mammografiya-raka-molochnoy-zhelezy-za-i-protiv?ysclid=lyphb4k637166672660.</mixed-citation><mixed-citation xml:lang="en">Komarova LE. Breast Cancer Screening Mammography: Pros and Cons? Siberian Journal of Oncology. 2008;S2:9–14. (In Russ.) Available at: https://cyberleninka.ru/article/n/skriningovaya-mammografiya-raka-molochnoy-zhelezy-za-i-protiv?ysclid=lyphb4k637166672660.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L. Early diagnosis of breast cancer. Sensors (Basel, Switzerland). 2017;17(7):1572. https://doi.org/10.3390/s17071572.</mixed-citation><mixed-citation xml:lang="en">Wang L. Early diagnosis of breast cancer. Sensors (Basel, Switzerland). 2017;17(7):1572. https://doi.org/10.3390/s17071572.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Држевецкая КС, Корженкова ГП. Проведение скрининга рака молочной железы в условиях неблагоприятной эпидемиологической ситуации COVID-19. Исследования и практика в медицине. 2021;8(3):34–44. https://doi.org/10.17709/2410-1893-2021-8-3-3.</mixed-citation><mixed-citation xml:lang="en">Drzhevetskaya KS, Korzhenkova GP. Breast cancer screening during the adverse COVID-19 epidemiological situation. Research and Practical Medicine Journal. 2021;8(3):34–44. (In Russ.) https://doi.org/10.17709/2410-1893-2021-8-3-3.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE et al. Shared decision making in preventive health care: What it is, what it is not. Can Fam Physician. 2017;63(9):682–684. https://doi.org/10.1007/s11606-012-2077-6.</mixed-citation><mixed-citation xml:lang="en">Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE et al. Shared decision making in preventive health care: What it is, what it is not. Can Fam Physician. 2017;63(9):682–684. https://doi.org/10.1007/s11606-012-2077-6.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. https://doi.org/10.1007/s11606-012-2077-6.</mixed-citation><mixed-citation xml:lang="en">Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. https://doi.org/10.1007/s11606-012-2077-6.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
